Trials / Active Not Recruiting
Active Not RecruitingNCT03018418
Proton Therapy in Reducing Toxicity in Anal Cancer
A Prospective Pilot Study to Evaluate the Feasibility of Intensity Modulated Proton Therapy in Reducing Toxicity in Anal Cancer
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Jordan Kharofa · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine whether the amount of radiation given to the normal areas around the anal cancer can be reduced by using Proton Therapy while reducing the side effects that are seen with standard therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Proton therapy | Primary target volume 50.4-54 CGE in 28-30 fractions; Nodal volumes 42-54 CGE in 28-30 fractions |
| DRUG | Chemotherapy | 5FU 1000 mg/m2/day as 96 hour infusion days 1-5 and 29-33; Mitomycin 10mg/m2 days 1 and 29 |
Timeline
- Start date
- 2017-01-04
- Primary completion
- 2022-04-07
- Completion
- 2025-07-01
- First posted
- 2017-01-12
- Last updated
- 2024-09-19
- Results posted
- 2023-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03018418. Inclusion in this directory is not an endorsement.